Symbols / STIM
STIM Chart
About
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 90.06M |
| Enterprise Value | 153.76M | Income | -44.50M | Sales | 129.87M |
| Book/sh | 0.40 | Cash/sh | 0.41 | Dividend Yield | — |
| Payout | 0.00% | Employees | 716 | IPO | — |
| P/E | — | Forward P/E | -2.77 | PEG | — |
| P/S | 0.69 | P/B | 3.29 | P/C | — |
| EV/EBITDA | -4.49 | EV/Sales | 1.18 | Quick Ratio | 1.62 |
| Current Ratio | 2.24 | Debt/Eq | 289.38 | LT Debt/Eq | — |
| EPS (ttm) | -0.83 | EPS next Y | -0.47 | EPS Growth | — |
| Revenue Growth | 101.30% | Earnings | 2026-03-17 | ROA | -21.21% |
| ROE | -218.99% | ROIC | — | Gross Margin | 50.89% |
| Oper. Margin | -19.63% | Profit Margin | -34.27% | Shs Outstand | 68.49M |
| Shs Float | 38.49M | Short Float | 21.63% | Short Ratio | 6.48 |
| Short Interest | — | 52W High | 5.92 | 52W Low | 1.25 |
| Beta | 0.81 | Avg Volume | 1.89M | Volume | 768.28K |
| Target Price | $6.50 | Recom | Buy | Prev Close | $1.27 |
| Price | $1.31 | Change | 3.54% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$6.50
Mean price target
2. Current target
$1.34
Latest analyst target
3. DCF / Fair value
$-4.57
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.34
Low
$5.50
High
$7.00
Mean
$6.50
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-08-06 | main | Canaccord Genuity | Buy → Buy | $7 |
| 2025-03-05 | main | Canaccord Genuity | Buy → Buy | $8 |
| 2025-03-05 | main | Citizens Capital Markets | Market Outperform → Market Outperform | $7 |
| 2024-08-14 | main | JMP Securities | Market Outperform → Market Outperform | $3 |
| 2024-08-13 | main | Canaccord Genuity | Buy → Buy | $3 |
| 2024-08-12 | down | William Blair | Outperform → Market Perform | — |
| 2024-05-14 | up | William Blair | Market Perform → Outperform | — |
| 2024-03-06 | reit | Piper Sandler | Overweight → Overweight | $8 |
| 2023-05-10 | reit | JMP Securities | — → Market Outperform | $12 |
| 2023-03-08 | main | Canaccord Genuity | — → Buy | $7 |
| 2023-03-08 | reit | JMP Securities | — → Market Outperform | $12 |
| 2021-10-14 | main | JMP Securities | — → Market Outperform | $12 |
| 2021-10-13 | down | BTIG | Buy → Neutral | — |
| 2021-01-22 | up | William Blair | Market Perform → Outperform | — |
| 2020-10-26 | main | Canaccord Genuity | — → Buy | $8 |
| 2020-10-06 | reit | BTIG | — → Buy | $10 |
| 2020-04-09 | main | Canaccord Genuity | — → Buy | $4 |
| 2019-11-06 | main | JMP Securities | — → Market Outperform | $12 |
| 2018-08-15 | main | JMP Securities | Market Outperform → Market Outperform | $40 |
| 2018-08-15 | main | Canaccord Genuity | Buy → Buy | $36 |
- Neuronetics lifts 2025 revenue 99%, books positive Q4 operating cash flow - Stock Titan ue, 10 Feb 2026 08
- $STIM stock is down 18% today. Here's what we see in our data. - Quiver Quantitative Mon, 17 Nov 2025 08
- Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On? - Benzinga Wed, 11 Feb 2026 08
- Neuronetics, Inc. (STIM) Stock Analysis: Unpacking The 128% Upside Potential - DirectorsTalk Interviews hu, 18 Sep 2025 07
- Neuronetics Inc (STIM) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance Mon, 03 Nov 2025 08
- Would You Still Hold Neuronetics Stock If It Fell Another 30%? - Trefis Wed, 24 Dec 2025 08
- Neuronetics (STIM) Is Down 9.0% After Turning Cash-Flow Positive On NeuroStar Demand Has The Bull Case Changed? - Sahm Sat, 14 Feb 2026 08
- Would Neuronetics (NASDAQ:STIM) Be Better Off With Less Debt? - simplywall.st Sat, 13 Dec 2025 08
- Neuronetics (NASDAQ: STIM) sole TMS provider to Elite DNA’s 30+ sites in 3‑year pact - Stock Titan hu, 30 Oct 2025 07
- Peering Into Neuronetics Inc's Recent Short Interest - Benzinga ue, 24 Feb 2026 14
- Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 95% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews hu, 21 Aug 2025 07
- Neuronetics (STIM): Losses Worsen Despite Revenue Growth Outpacing Market Narrative - Yahoo Finance ue, 04 Nov 2025 08
- Neuronetics, Inc. Announces Q3 2025 Financial Results Release and Conference Call Schedule | STIM Stock News - Quiver Quantitative ue, 21 Oct 2025 07
- Assessing Neuronetics (STIM) Valuation After Positive Cash Flow And Strong Preliminary Q4 Revenue - Yahoo Finance Fri, 13 Feb 2026 08
- Neuronetics, Inc. (STIM) Stock Analysis: Exploring a Bold 98.78% Upside Potential in Healthcare - DirectorsTalk Interviews hu, 04 Sep 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 33847 | 55848 | — | Sale at price 1.65 per share. | SULLIVAN KEITH J | Chief Executive Officer | — | 2026-02-12 00:00:00 | D |
| 1 | 14120 | 23298 | — | Sale at price 1.65 per share. | MACAN WILLIAM ANDREW | Officer | — | 2026-02-12 00:00:00 | D |
| 2 | 40976 | 63513 | — | Sale at price 1.55 per share. | SULLIVAN KEITH J | Chief Executive Officer | — | 2026-02-10 00:00:00 | D |
| 3 | 3485 | 5402 | — | Sale at price 1.55 per share. | MACAN WILLIAM ANDREW | Officer | — | 2026-02-10 00:00:00 | D |
| 4 | 164361 | — | — | Stock Award(Grant) at price 0.00 per share. | MACAN WILLIAM ANDREW | General Counsel | — | 2025-12-30 00:00:00 | D |
| 5 | 170212 | — | — | Stock Award(Grant) at price 0.00 per share. | PFANSTIEL STEVEN | Officer | — | 2025-12-30 00:00:00 | D |
| 6 | 7554 | — | — | Stock Award(Grant) at price 0.00 per share. | MUIR GLENN P | Director | — | 2025-10-20 00:00:00 | D |
| 7 | 10531 | — | — | Stock Award(Grant) at price 0.00 per share. | CASCELLA ROBERT A | Director | — | 2025-10-20 00:00:00 | D |
| 8 | 7326 | — | — | Stock Award(Grant) at price 0.00 per share. | CONLEY SHERYL L | Director | — | 2025-10-20 00:00:00 | D |
| 9 | 6410 | — | — | Stock Award(Grant) at price 0.00 per share. | CUCUZ SASHA | Director | — | 2025-10-20 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -30.74M | -23.36M | -31.96M | -26.81M |
| TotalUnusualItems | -4.43M | 0.00 | 0.00 | 0.00 |
| TotalUnusualItemsExcludingGoodwill | -4.43M | 0.00 | 0.00 | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | -43.71M | -30.19M | -37.16M | -31.19M |
| ReconciledDepreciation | 2.07M | 2.01M | 1.65M | 1.06M |
| ReconciledCostOfRevenue | 20.73M | 19.64M | 15.48M | 11.65M |
| EBITDA | -35.17M | -23.36M | -31.96M | -26.81M |
| EBIT | -37.24M | -25.36M | -33.61M | -27.87M |
| NetInterestIncome | -7.30M | -5.40M | -4.30M | -4.00M |
| InterestExpense | 6.50M | 4.80M | 3.60M | 3.30M |
| NormalizedIncome | -39.28M | -30.19M | -37.16M | -31.19M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -43.71M | -30.19M | -37.16M | -31.19M |
| TotalExpenses | 109.45M | 101.90M | 100.32M | 82.88M |
| TotalOperatingIncomeAsReported | -34.56M | -30.55M | -35.11M | -27.56M |
| DilutedAverageShares | 31.63M | 28.66M | 26.90M | 25.48M |
| BasicAverageShares | 31.63M | 28.66M | 26.90M | 25.48M |
| DilutedEPS | -1.37 | -1.05 | -1.38 | -1.22 |
| BasicEPS | -1.37 | -1.05 | -1.38 | -1.22 |
| DilutedNIAvailtoComStockholders | -43.71M | -30.19M | -37.16M | -31.19M |
| NetIncomeCommonStockholders | -43.71M | -30.19M | -37.16M | -31.19M |
| NetIncome | -43.71M | -30.19M | -37.16M | -31.19M |
| MinorityInterests | 19.00K | 0.00 | 0.00 | |
| NetIncomeIncludingNoncontrollingInterests | -43.74M | -30.16M | -37.21M | -31.17M |
| NetIncomeContinuousOperations | -43.74M | -30.16M | -37.21M | -31.17M |
| PretaxIncome | -43.74M | -30.16M | -37.21M | -31.17M |
| OtherIncomeExpense | -1.88M | 5.79M | 2.20M | 390.00K |
| OtherNonOperatingIncomeExpenses | 2.55M | 5.79M | 2.20M | 390.00K |
| SpecialIncomeCharges | -4.43M | 0.00 | 0.00 | 0.00 |
| OtherSpecialCharges | 4.43M | |||
| NetNonOperatingInterestIncomeExpense | -7.30M | -5.40M | -4.30M | -4.00M |
| TotalOtherFinanceCost | 800.00K | 600.00K | 700.00K | 700.00K |
| InterestExpenseNonOperating | 6.50M | 4.80M | 3.60M | 3.30M |
| OperatingIncome | -34.56M | -30.55M | -35.11M | -27.56M |
| OperatingExpense | 88.72M | 82.26M | 84.83M | 71.22M |
| ResearchAndDevelopment | 12.77M | 9.52M | 9.34M | 7.92M |
| SellingGeneralAndAdministration | 75.95M | 72.74M | 75.50M | 63.30M |
| SellingAndMarketingExpense | 45.63M | 47.32M | 49.98M | 37.75M |
| GeneralAndAdministrativeExpense | 30.32M | 25.43M | 25.52M | 25.55M |
| OtherGandA | 30.32M | 25.43M | 25.52M | 25.55M |
| GrossProfit | 54.16M | 51.70M | 49.72M | 43.66M |
| CostOfRevenue | 20.73M | 19.64M | 15.48M | 11.65M |
| TotalRevenue | 74.89M | 71.35M | 65.21M | 55.31M |
| OperatingRevenue | 74.89M | 71.35M | 65.21M | 55.31M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 55.68M | 29.09M | 27.27M | 26.39M |
| ShareIssued | 55.68M | 29.09M | 27.27M | 26.39M |
| NetDebt | 36.69M | |||
| TotalDebt | 82.63M | 62.47M | 39.74M | 39.54M |
| TangibleBookValue | -10.53M | 34.19M | 57.06M | 85.17M |
| InvestedCapital | 82.86M | 93.47M | 93.01M | 120.51M |
| WorkingCapital | 26.86M | 73.98M | 65.57M | 99.63M |
| NetTangibleAssets | -10.53M | 34.19M | 57.06M | 85.17M |
| CapitalLeaseObligations | 27.48M | 3.19M | 3.79M | 4.21M |
| CommonStockEquity | 27.71M | 34.19M | 57.06M | 85.17M |
| TotalCapitalization | 82.86M | 93.47M | 79.89M | 120.51M |
| TotalEquityGrossMinorityInterest | 31.80M | 34.19M | 57.06M | 85.17M |
| MinorityInterest | 4.09M | 0.00 | ||
| StockholdersEquity | 27.71M | 34.19M | 57.06M | 85.17M |
| RetainedEarnings | -419.79M | -376.08M | -345.89M | -308.73M |
| AdditionalPaidInCapital | 446.94M | 409.98M | 402.68M | 393.64M |
| CapitalStock | 557.00K | 291.00K | 273.00K | 264.00K |
| CommonStock | 557.00K | 291.00K | 273.00K | 264.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 109.10M | 81.64M | 59.82M | 56.05M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 77.84M | 61.83M | 26.62M | 40.34M |
| NonCurrentDeferredLiabilities | 2.00K | 200.00K | 829.00K | 1.47M |
| NonCurrentDeferredRevenue | 2.00K | 200.00K | 829.00K | 1.47M |
| LongTermDebtAndCapitalLeaseObligation | 77.84M | 61.63M | 25.80M | 38.87M |
| LongTermCapitalLeaseObligation | 22.69M | 2.35M | 2.97M | 3.54M |
| LongTermDebt | 55.15M | 59.28M | 22.83M | 35.34M |
| CurrentLiabilities | 31.27M | 19.81M | 33.20M | 15.70M |
| CurrentDeferredLiabilities | 1.97M | 1.62M | 1.98M | 2.50M |
| CurrentDeferredRevenue | 974.00K | 1.62M | 1.98M | 2.50M |
| CurrentDebtAndCapitalLeaseObligation | 4.79M | 845.00K | 13.95M | 670.00K |
| CurrentCapitalLeaseObligation | 4.79M | 845.00K | 824.00K | 670.00K |
| CurrentDebt | 13.12M | |||
| OtherCurrentBorrowings | 13.12M | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 7.95M | 8.00M | 11.20M | 5.09M |
| CurrentProvisions | 306.00K | |||
| PayablesAndAccruedExpenses | 16.55M | 9.34M | 6.07M | 7.44M |
| CurrentAccruedExpenses | 4.25M | 3.77M | 2.98M | 2.48M |
| Payables | 12.30M | 5.57M | 3.09M | 4.96M |
| OtherPayable | 605.00K | |||
| TotalTaxPayable | 619.00K | 818.00K | 659.00K | 664.00K |
| AccountsPayable | 11.08M | 4.75M | 2.43M | 4.30M |
| TotalAssets | 140.90M | 115.83M | 116.88M | 141.22M |
| TotalNonCurrentAssets | 82.78M | 22.04M | 18.11M | 25.89M |
| OtherNonCurrentAssets | 1.92M | 4.43M | 3.65M | 2.22M |
| NonCurrentPrepaidAssets | 8.90M | 8.37M | 7.57M | 6.76M |
| NonCurrentNoteReceivables | 295.00K | 3.79M | 362.00K | 10.11M |
| InvestmentsAndAdvances | 86.00K | 661.00K | 1.22M | 1.70M |
| OtherInvestments | 86.00K | 661.00K | 1.22M | 1.70M |
| GoodwillAndOtherIntangibleAssets | 38.24M | 0.00 | ||
| OtherIntangibleAssets | 19.61M | |||
| Goodwill | 18.63M | 0.00 | ||
| NetPPE | 33.34M | 4.78M | 5.32M | 5.10M |
| AccumulatedDepreciation | -3.24M | -2.82M | -3.06M | -2.54M |
| GrossPPE | 36.58M | 7.60M | 8.38M | 7.64M |
| Leases | 1.61M | 1.44M | 1.44M | 471.00K |
| OtherProperties | 28.92M | 4.57M | 4.67M | 5.08M |
| MachineryFurnitureEquipment | 6.05M | 1.60M | 2.27M | 2.10M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 58.12M | 93.79M | 98.77M | 115.33M |
| OtherCurrentAssets | 6.85M | 4.77M | 2.17M | 3.09M |
| RestrictedCash | 1.00M | 0.00 | ||
| PrepaidAssets | 3.08M | 2.51M | 2.00M | 1.56M |
| Inventory | 4.25M | 8.09M | 8.90M | 6.56M |
| Receivables | 24.29M | 17.84M | 13.82M | 7.78M |
| NotesReceivable | 930.00K | 2.06M | 230.00K | 74.00K |
| AccountsReceivable | 23.36M | 15.78M | 13.59M | 7.71M |
| AllowanceForDoubtfulAccountsReceivable | -1.93M | -795.00K | -1.65M | -1.46M |
| GrossAccountsReceivable | 25.29M | 16.58M | 15.24M | 9.17M |
| CashCashEquivalentsAndShortTermInvestments | 18.66M | 60.58M | 71.88M | 96.34M |
| OtherShortTermInvestments | 206.00K | 905.00K | 1.54M | 2.20M |
| CashAndCashEquivalents | 18.46M | 59.68M | 70.34M | 94.14M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -32.46M | -34.41M | -34.01M | -30.34M |
| RepaymentOfDebt | -60.00M | -1.20M | 0.00 | 0.00 |
| IssuanceOfDebt | 57.48M | 25.00M | 0.00 | 0.00 |
| IssuanceOfCapitalStock | 0.00 | 0.00 | 80.97M | |
| CapitalExpenditure | -1.47M | -2.37M | -3.27M | -2.35M |
| InterestPaidSupplementalData | 6.51M | 4.79M | 3.54M | 3.30M |
| EndCashPosition | 19.46M | 59.68M | 70.34M | 94.14M |
| BeginningCashPosition | 59.68M | 70.34M | 94.14M | 48.96M |
| ChangesInCash | -40.22M | -10.66M | -23.80M | 45.18M |
| FinancingCashFlow | -6.81M | 22.70M | 207.00K | 83.01M |
| CashFlowFromContinuingFinancingActivities | -6.81M | 22.70M | 207.00K | 83.01M |
| NetOtherFinancingCharges | -6.81M | -1.10M | -91.00K | -401.00K |
| ProceedsFromStockOptionExercised | 2.52M | 1.00K | 298.00K | 2.44M |
| NetCommonStockIssuance | 0.00 | 0.00 | 80.97M | |
| CommonStockIssuance | 0.00 | 0.00 | 80.97M | |
| NetIssuancePaymentsOfDebt | -2.52M | 23.80M | 0.00 | 0.00 |
| NetLongTermDebtIssuance | -2.52M | 23.80M | 0.00 | 0.00 |
| LongTermDebtPayments | -60.00M | -1.20M | 0.00 | 0.00 |
| LongTermDebtIssuance | 57.48M | 25.00M | 0.00 | 0.00 |
| InvestingCashFlow | -2.41M | -1.32M | 6.73M | -9.84M |
| CashFlowFromContinuingInvestingActivities | -2.41M | -1.32M | 6.73M | -9.84M |
| NetOtherInvestingChanges | 1.61M | 1.05M | 10.00M | -7.49M |
| NetInvestmentPurchaseAndSale | 10.00M | -7.49M | ||
| NetBusinessPurchaseAndSale | -2.55M | 0.00 | 0.00 | |
| PurchaseOfBusiness | -2.55M | 0.00 | 0.00 | |
| NetPPEPurchaseAndSale | -1.47M | -2.37M | -3.27M | -2.35M |
| PurchaseOfPPE | -1.47M | -2.37M | -3.27M | -2.35M |
| OperatingCashFlow | -31.00M | -32.04M | -30.74M | -27.98M |
| CashFlowFromContinuingOperatingActivities | -31.00M | -32.04M | -30.74M | -27.98M |
| ChangeInWorkingCapital | -6.81M | -14.10M | -5.12M | -7.40M |
| ChangeInOtherWorkingCapital | -843.00K | -989.00K | -1.16M | 215.00K |
| ChangeInOtherCurrentLiabilities | -66.00K | 0.00 | 0.00 | |
| ChangeInOtherCurrentAssets | 997.00K | 1.19M | 1.11M | 324.00K |
| ChangeInPayablesAndAccruedExpense | -4.07M | -214.00K | 4.64M | 1.19M |
| ChangeInAccruedExpense | -2.08M | -2.24M | 6.60M | 910.00K |
| ChangeInPayable | -1.99M | 2.03M | -1.97M | 276.00K |
| ChangeInAccountPayable | -1.99M | 2.03M | -1.97M | 276.00K |
| ChangeInPrepaidAssets | -2.25M | -4.16M | -457.00K | -1.86M |
| ChangeInInventory | 3.15M | -1.10M | -2.59M | -3.44M |
| ChangeInReceivables | -3.73M | -8.83M | -6.66M | -3.82M |
| ChangesInAccountReceivables | -3.73M | -8.83M | -6.66M | -3.82M |
| OtherNonCashItems | 771.00K | 634.00K | 801.00K | 918.00K |
| StockBasedCompensation | 5.60M | 7.32M | 8.75M | 7.87M |
| ProvisionandWriteOffofAssets | 2.06M | 390.00K | 341.00K | 763.00K |
| AssetImpairmentCharge | 4.58M | 1.91M | 0.00 | 0.00 |
| DepreciationAmortizationDepletion | 2.07M | 2.01M | 1.65M | 1.06M |
| DepreciationAndAmortization | 2.07M | 2.01M | 1.65M | 1.06M |
| OperatingGainsLosses | 4.46M | |||
| GainLossOnSaleOfPPE | 28.00K | 0.00 | 0.00 | |
| NetIncomeFromContinuingOperations | -43.73M | -30.19M | -37.16M | -31.19M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for STIM
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|